Item 2.02. Results of Operations and Financial Condition On August 6, 2026, Evolent Health, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026, a copy of which is furnished herewith as Exhibit 99.1.…
Filed Aug 6, 2026Accepted Aug 6, 2026, 7:03 AM EDTCIK 1628908Accession 0001628908-26-000084
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition
On August 6, 2026, Evolent Health, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026, a copy of which is furnished herewith as Exhibit 99.1.
The information, including Exhibit 99.1 hereto, furnished under this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject the Company or any other person to liability under that Section, to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.